In focus
Latest feed
A Lifeline and a Leap: Aligos Therapeutics Stock Soars on Crucial $25M China Hepatitis B Drug Deal
Chemists Across India Plan May 20 Strike Over E‑Pharmacy Rules and Delayed GSR Notifications
The Price of Life: Will South Africa Gain Access to Gilead's Breakthrough HIV Drug?
A Strategic Handshake: Astria Therapeutics Licenses Key Drug to BioCryst, Redefining Focus